RPEAX
Price
$42.67
Change
+$0.13 (+0.31%)
Updated
Oct 17 closing price
Net Assets
596.91M
VFIAX
Price
$615.34
Change
+$3.24 (+0.53%)
Updated
Oct 17 closing price
Net Assets
1.41T
Interact to see
Advertisement

RPEAX vs VFIAX

Header iconRPEAX vs VFIAX Comparison
Open Charts RPEAX vs VFIAXBanner chart's image
Davis Opportunity A
Price$42.67
Change+$0.13 (+0.31%)
VolumeN/A
Net Assets596.91M
Vanguard 500 Index Admiral
Price$615.34
Change+$3.24 (+0.53%)
VolumeN/A
Net Assets1.41T
RPEAX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
RPEAX vs. VFIAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPEAX is a Hold and VFIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.41T vs. RPEAX (597M). VFIAX pays higher dividends than RPEAX: VFIAX (1.14) vs RPEAX (0.85). RPEAX was incepted earlier than VFIAX: RPEAX (31 years) vs VFIAX (25 years). RPEAX (0.93) is less costly to investors than VFIAX (0.04). RPEAX is a more actively managed with annual turnover of: 23.00 vs. VFIAX (2.00). RPEAX has a lower initial minimum investment than VFIAX: RPEAX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 13.55 vs. RPEAX (-3.30). VFIAX return over 5 years is better than : 90.55 vs. RPEAX (30.27).
RPEAXVFIAXRPEAX / VFIAX
Total Expense Ratio0.930.042,325%
Annual Report Gross Expense Ratio0.930.042,325%
Fund Existence31 years25 years-
Gain YTD15.54312.816121%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets597M1.41T0%
Annual Yield % from dividends0.851.1475%
Returns for 1 year-3.3013.55-24%
Returns for 3 years30.7378.4539%
Returns for 5 years30.2790.5533%
Returns for 10 years35.18226.9716%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INVE3.860.35
+9.97%
Identiv
ROIV17.260.15
+0.88%
Roivant Sciences Ltd
ARDT14.630.04
+0.27%
Ardent Health Inc
ADCT4.08-0.05
-1.21%
ADC Therapeutics SA
CERO1.99-0.38
-16.03%
CERO Therapeutics Holdings Inc